Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older at the time of re-irradiation (receiving radiation treatment again) or when enrolled in the trial
- People who have been diagnosed with a gynaecologic cancer (such as uterine, cervical, vaginal, vulvar, ovarian, fallopian tube, or related cancers) confirmed through a tissue or cell sample
- People who have previously received radiation therapy as part of their cancer treatment
- People whose cancer has come back or continued to grow, and for whom a second course of radiation or a full ablative (tumour-destroying) radiation strategy has been given, is currently underway, or is being planned based on a specialist team's recommendation
- People whose cancer recurrence or progression has been confirmed through scans, physical examination, tissue testing, or a specialist tumour board review
- People for whom the minimum required medical records are available, including details of prior radiation treatment, the date of re-irradiation, the extent of disease at that time, and at least one follow-up or survival record (for patients included from past records)
- People enrolling prospectively (going forward) who have provided written consent where this is required by local rules and ethics approval
Who may not be able to join:
- People with no record of having received radiation therapy previously
- People who have not received, and do not have a plan to receive, a second course of radiation or a meaningful ablative radiation treatment
- People whose medical records are too incomplete to establish the date of re-irradiation, the extent of disease, or follow-up and survival information
- People whose cancer has spread widely to more than 5 active sites outside the local or regional area, and whose treatment did not include a meaningful local re-irradiation or ablative component — unless a specific sub-study approved by the trial's steering committee applies (confirm with trial site)
- People who decline to give consent when consent is required under local law or ethics approval
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 84 535 99 10
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Radiographic Progression-Free Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.